Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma

Author:

Sauer Maike1,Plütschow Annette2,Jachimowicz Ron D.,Kleefisch Dominik1,Reiners Katrin S.1,Ponader Sabine,Engert Andreas2,von Strandmann Elke Pogge1

Affiliation:

1. Department of Internal Medicine I; Laboratory for Immunotherapy; University Hospital Cologne; Cologne; Germany

2. Department of Internal Medicine I; German Hodgkin Study Group; University Hospital Cologne; Cologne; Germany

Publisher

Wiley

Subject

Hematology

Reference11 articles.

1. Hodgkin's lymphoma: Current treatment strategies and novel approaches;Eichenauer;Expert Rev Hematol,2008

2. Late effects of treatment for Hodgkin lymphoma;Friedman;J Natl Compr Cancer Network: JNCCN,2006

3. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease;Hasenclever;NEngl J Med,1998

4. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC;Hnatkova;Prague Med Rep,2009

5. Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues;Maggio;Ann Oncol,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3